Pzifer Says Antiviral Drug to Treat Coronavirus Could Be Available by Year’s End

Click here to read full article 

Pfiz­er CEO and chair­man Albert Bourla says that the bio­phar­ma­ceu­ti­cal com­pa­ny behind the COVID-19 vac­cine could pub­licly release an antivi­ral drug designed to treat the coro­n­avirus by the end of 2021.
What are the details?
Bourla on Mon­day told CNBC’s “Squawk Box” that the drug — called PF-07321332 — is an antivi­ral drug intend­ed for oral inges­tion in COVID-19-pos­i­tive patients when the ill­ness is first detect­ed. The com­pa­ny is also test­ing an intra­venous option.

The treat­ment is antic­i­pat­ed to be effec­tive against vary­ing strains of the dead­ly virus.

Bourla said that the com­pa­ny is zero­ing in on the oral option as it ” …


Big Tech is at war with you! They don't want you to see the truth.



Send this to a friend